Major Revision at JAMA: What It Means, Next Steps

The decisive line is whether the editors still see a path to publication at the flagship. A major revision keeps your manuscript active at JAMA, which is materially stronger than a reject-with-referral that sends the paper to a different JAMA Network editorial team and a different readership bar.

JAMA does not report an acceptance-after-major-revision rate, so any precise JAMA-specific number you encounter is fabricated. The defensible framing rests on two verifiable facts: JAMA's overall acceptance rate is 10%, and a manuscript at major revision has already passed the editors' initial review and a round of external review.

• Reaching a major revision means you cleared the initial editor review that rejects manuscripts with insufficient priority promptly.

• Editorial commitment is real but conditional: final decisions are made by an editor with no relevant conflicts of interest, so a strong re-review is necessary but not sufficient.

• The general cross-journal figure that 60 to 80 percent of major revisions are eventually accepted is a useful prior, but JAMA accepts only 10% of submissions overall, so treat it as a ceiling on optimism.

Spend your energy resolving every reviewer concern in the response rather than estimating a percentage JAMA does not publish.

JAMA does not publish a standard revision window or re-review duration. The decision letter specifies the deadline, and missing it without contact risks converting the major revision into a withdrawn file, so the date in the letter is load-bearing.

If the analyses will not fit the window, contact the editorial office (contact details are in the JAMA Instructions for Authors) through the JAMA manuscript submission system with your manuscript number before the deadline. JAMA does not publish an extension policy; the avoidable failure is going silent and resurfacing after the window has closed.

Hold the revised manuscript within JAMA length norms while you add the requested analyses: a JAMA Original Investigation is limited to 3,000 words of body text with a structured abstract capped at 350 words, and tables, figures, and the supplement absorb the overflow. If a major revision pushes the paper past those limits, plan the trim before you resubmit.

Confirm access economics too: the JAMA flagship charges no author fees and has no open access option, so the funder conversation belongs in the revision window rather than after a positive decision. Research articles are free to read 6 months after publication, and authors may deposit the accepted manuscript in a public repository on the date of acceptance, provided it is not made public until publication.

JAMA does not publish how re-review is organized. Plan for the editors and reviewers to read your point-by-point response before they re-read the manuscript, and to re-check the reporting checklist and statistical analysis plan. Expect them to look for whether your revision addresses every reviewer point.

Your decision letter sets what to resubmit; the usual package is the revised manuscript, a cover letter, and a point-by-point response that addresses every reviewer comment. The response is what the reviewers and editors read first.

1. Detail in the response, overview in the letter. Develop the comment-by-comment clinical engagement in the separate point-by-point response and keep the cover letter to a short overview of the changes; route statistical comments to a dedicated thread tied to the analysis plan.

1. Echo the comment, document the action, cite the spot. Echo each comment, document the action you took, and cite the exact Methods paragraph, table, figure, or reporting-checklist item that changed.

1. Re-anchor general-medicine relevance where that was the concern. If a reviewer or editor questioned readership fit rather than rigor, move the practice, policy, or interpretation implication into the abstract and first page.

1. Close every statistical and reporting gap traceably. Make CONSORT, STROBE, or PRISMA items, prespecified outcomes, multiplicity adjustment, and missing-data handling trace to specific locations, and report effect sizes and confidence intervals, not p-values alone.

1. Do not introduce unrequested analyses. Adding new analyses or findings the reviewers did not request resets the editorial clock and raises questions about the stability of the original work.

Route your revised manuscript through a JAMA point-by-point response check so the general-medicine framing and reporting-checklist completeness are verified against the clinical and statistical reviewers' concerns before you resubmit.

• Do not introduce new analyses or findings the reviewers did not request. This resets the editorial clock and questions the stability of the original work.

• Do not leave the general-medicine relevance in the discussion while only adding analyses. Reviewers and editors re-check the framing.

• Do not skimp on the CONSORT, STROBE, or PRISMA checklist or the statistical analysis plan. Reviewers re-check these directly.

• Do not report results as P values alone. JAMA's instructions say P values should never be presented alone without the data being compared; report effect sizes, confidence intervals, and absolute risk differences.

• Do not answer a statistical or methods concern with a combative rebuttal. A reviewer re-reading a defensive response weighs the revised analysis more skeptically.

• Do not miss the deadline in the decision letter without contact, which can convert the revision into a withdrawn file.

Across JAMA manuscripts, three patterns most often turn a possible acceptance into a major revision, and the same three most often decide whether the revision then survives re-review. These are anonymized observations from Manusights pre-submission and revision review, not access to JAMA Network editorial records. Each is a named failure pattern tied to a specific JAMA editorial expectation, and in practice we see them recur across the manuscripts we screen.

The useful question for a revising author is whether the revised abstract, Methods, reporting checklist, statistical analysis plan, and response already answer the concern in the manuscript itself.

General-medicine relevance stranded in the discussion while the framing stays specialty-only.

In JAMA manuscripts, the most common reason for a major revision is not a weak clinical question but a general-medicine implication that lives in the discussion rather than the abstract and first page. In our pre-submission work, the most common desk-rejection reason is insufficient general-medicine readership fit, and that same filter resurfaces on re-review: a paper excellent for cardiology, oncology, or infectious-disease readers earns a major revision to force the framing to explain why a general clinical audience should change interpretation, screening, diagnosis, or treatment.

The strongest revisions move that broader implication into the structured abstract and the first page, then carry it through the discussion. A revision that adds analyses without re-anchoring the general-medicine relevance leaves the same editorial concern in place.

Reporting-checklist and statistical-analysis-plan gaps that re-review tests directly. In JAMA manuscripts, reviewers frequently grant a major revision while flagging incomplete CONSORT, STROBE, or PRISMA items, unclear prespecified outcomes, missing-data handling that is not described, undeclared multiplicity adjustment, or trial-registration timing that does not line up with the analysis plan.

Because reviewers re-check the revision directly, the path to acceptance runs through the Methods, the checklist, and the statistical analysis plan. The strongest revisions make every checklist item and every prespecified outcome trace to a specific Methods paragraph, table, or figure, and distinguish prespecified from post-hoc analyses explicitly, so the re-reviewer can verify the fix without reconstructing it.

Results reported as p-values without effect sizes, confidence intervals, or absolute risk. In JAMA manuscripts, a major revision often reflects results reported as statistical significance alone. JAMA's instructions say P values should never be presented alone, because clinicians and editors want effect sizes, confidence intervals, number needed to treat, and absolute risk differences that tell a reader how large the effect is, not only whether it is non-random.

The strongest revisions re-report the primary and key secondary outcomes with effect sizes and confidence intervals, add absolute risk differences and NNT where relevant, and avoid introducing unrequested new analyses while doing so. This is a clinical-statistics test, not a generic significance test, and it is where the statistical re-review is won or lost.

This page tells you what JAMA editors and reviewers look for when they re-read a revised manuscript. The review tells you whether YOUR revised paper and response pass that check before you resubmit.

Use this page when you have just received a major revision at JAMA and need to decide what to fix first, given that the editors make the final call.

We have reviewed manuscripts targeting JAMA and peer general-medicine venues in pre-submission and revision contexts; the named patterns above are the same ones reviewers flag on re-review. 60-day money-back guarantee. Your manuscript is not used for model training, and access is limited to the review workflow.

Of the manuscripts our team reviewed for this JAMA decision-outcome pattern sample, the strongest predictor of a clean re-review was whether the response closed every general-medicine-framing, reporting-checklist, and statistical-reporting concern with an exact, already-present manuscript location, and reported effect sizes and confidence intervals rather than p-values alone, instead of adding unrequested analyses that reset the editorial clock.

Check whether your JAMA revision is re-review ready

If a JAMA revision is rejected after re-review, the cascade depends on what the reviewers and editors cited.

JAMA Network Open is the natural JAMA Network cascade for rigorous clinical research whose general-medicine readership fit at the flagship is not met; JAMA Network lets authors preselect referral at submission, with reviewers' comments if available.

JAMA Internal Medicine and the JAMA specialty journals (JAMA Cardiology, JAMA Oncology, JAMA Neurology, JAMA Pediatrics) are JAMA Network cascades where the specialty editorial scope fits.

NEJM, The Lancet, and BMJ are external general-medicine cascades; reports do not transfer, but a documented JAMA revision strengthens a fresh submission.

This page was created from:

• JAMA's public Instructions for Authors at Jamanetwork author instructions

• JAMA Network editorial documentation (10% acceptance, 4% research acceptance, the appeal process, and the Original Investigation word and abstract limits)

• the JAMA Editors Guide for Authors on responding to decision letters

• the broader peer-review literature on major-revision handling

• Manusights pre-submission and revision review experience with JAMA-targeted manuscripts.

Source limitations: JAMA publishes its editorial criteria and appeal process, but it does not publish a revision window, a re-review structure, or a journal-specific acceptance-after-major-revision rate. Any precise JAMA-specific revision-acceptance percentage is therefore not verifiable; the 60 to 80 percent figure above is a general cross-journal range, not a JAMA number, and JAMA is far more selective than the journals that range describes.

The named revision patterns are Manusights interpretation from pre-submission and revision review, not private JAMA Network records.